Комбинированная химиотерапия как первая линия лечения диссеминированных семином

A. Garin, С. А. Тюляндин, A V Khlebnov et al. · Вестник РОНЦ им. Н. Н. Блохина РАМН · 1990

We evaluated the treatment results of nonrandomized study in 41 patients with disseminated seminoma: 16 patients were treated with VAB-6 combination, 25 with CC combination: cyclophosphamide 1 g/m iv Id, cisplatin 100 mg/m iv d 2, 9, 16. After VAB-6 CR was observed in 8 patients and 4 patients were salvaged with further therapy: 1 chemotherapy and 3 radiation therapy (RT). Final CR rate was 75%. At medial follow up of 38 (11-70) months, 11 patients remained free of disease, 1 alive with relapse and 4 patients died. From 25 patients treated with CC alone only 12 achieved CR and 4 were salvaged with RT; CR rate was 64 %. Medial follow up is 22 (11-39) months, 15 patients remained free of disease, 5 alive with stable residual mass, 1 died and 4 patients had been lost for follow up. Both regimens were well tolerated, the main toxicity was leucopenia; 62% (WHO grade lll_IV-7%) for VAB-6, 92% (18%) for CC. No fetal toxicity occurred. Thus, VAB-6 and CC regimens seem to have compatible high activity in disseminated seminoma.

Cited by 0 works.

Authors